Annual FCF:
-$264.58M-$5.31B(-105.25%)Summary
- As of today, BNTX annual free cash flow is -$264.58 million, with the most recent change of -$5.31 billion (-105.25%) on December 31, 2024.
- During the last 3 years, BNTX annual free cash flow has fallen by -$1.13 billion (-130.43%).
- BNTX annual free cash flow is now -101.91% below its all-time high of $13.89 billion, reached on December 31, 2022.
Performance
BNTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
$700.03M+$2.17B(+147.55%)Summary
- As of today, BNTX quarterly free cash flow is $700.03 million, with the most recent change of +$2.17 billion (+147.55%) on June 30, 2025.
- Over the past year, BNTX quarterly free cash flow has dropped by -$907.35 million (-56.45%).
- BNTX quarterly free cash flow is now -85.29% below its all-time high of $4.76 billion, reached on September 30, 2022.
Performance
BNTX Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$2.15B-$907.35M(-72.87%)Summary
- As of today, BNTX TTM free cash flow is -$2.15 billion, with the most recent change of -$907.35 million (-72.87%) on June 30, 2025.
- Over the past year, BNTX TTM free cash flow has dropped by -$5.14 billion (-172.00%).
- BNTX TTM free cash flow is now -115.62% below its all-time high of $13.78 billion, reached on December 31, 2022.
Performance
BNTX TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
BNTX Free Cash Flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | -105.3% | -56.5% | -172.0% |
3Y3 Years | -130.4% | -82.9% | -121.5% |
5Y5 Years | +12.3% | +2070.2% | -402.6% |
BNTX Free Cash Flow Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | -101.9% | at low | -85.3% | +147.6% | -115.6% | at low |
5Y | 5-Year | -101.9% | +12.3% | -85.3% | +147.6% | -115.6% | at low |
All-Time | All-Time | -101.9% | +12.3% | -85.3% | +147.6% | -115.6% | at low |
BNTX Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $700.03M(+147.6%) | -$2.15B(-72.9%) |
Mar 2025 | - | -$1.47B(-144.7%) | -$1.25B(-368.1%) |
Dec 2024 | -$264.58M(-105.2%) | -$601.69M(+22.7%) | -$266.00M(-118.0%) |
Sep 2024 | - | -$778.73M(-148.4%) | $1.48B(-50.5%) |
Jun 2024 | - | $1.61B(+426.1%) | $2.99B(-48.3%) |
Mar 2024 | - | -$492.97M(-143.1%) | $5.78B(+5.1%) |
Dec 2023 | $5.04B(-63.7%) | $1.14B(+56.0%) | $5.50B(+14.6%) |
Sep 2023 | - | $732.32M(-83.4%) | $4.80B(-45.6%) |
Jun 2023 | - | $4.40B(+667.6%) | $8.83B(+3.5%) |
Mar 2023 | - | -$775.31M(-275.1%) | $8.53B(-38.1%) |
Dec 2022 | $13.89B(+1497.0%) | $442.74M(-90.7%) | $13.78B(+5.8%) |
Sep 2022 | - | $4.76B(+16.0%) | $13.03B(+30.0%) |
Jun 2022 | - | $4.10B(-8.3%) | $10.02B(+74.0%) |
Mar 2022 | - | $4.48B(+1529.5%) | $5.76B(+561.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | $869.58M(+871.1%) | -$313.07M(-117.9%) | $870.50M(-38.5%) |
Sep 2021 | - | $1.75B(+1215.4%) | $1.42B(+346.0%) |
Jun 2021 | - | -$156.95M(+61.7%) | -$575.28M(-26.8%) |
Mar 2021 | - | -$410.13M(-277.0%) | -$453.87M(-300.7%) |
Dec 2020 | -$112.77M(+62.6%) | $231.66M(+196.6%) | -$113.26M(+73.6%) |
Sep 2020 | - | -$239.87M(-575.1%) | -$428.28M(-61.4%) |
Jun 2020 | - | -$35.53M(+48.9%) | -$265.36M(+10.8%) |
Mar 2020 | - | -$69.52M(+16.6%) | -$297.59M(+1.4%) |
Dec 2019 | -$301.77M(-103.0%) | -$83.36M(-8.3%) | -$301.82M(-38.2%) |
Sep 2019 | - | -$76.95M(-13.6%) | -$218.46M(-54.4%) |
Jun 2019 | - | -$67.76M(+8.1%) | -$141.51M(-91.9%) |
Mar 2019 | - | -$73.75M | -$73.75M |
Dec 2018 | -$148.69M(-19.5%) | - | - |
Dec 2017 | -$124.42M | - | - |
FAQ
- What is BioNTech SE annual free cash flow?
- What is the all-time high annual free cash flow for BioNTech SE?
- What is BioNTech SE annual free cash flow year-on-year change?
- What is BioNTech SE quarterly free cash flow?
- What is the all-time high quarterly free cash flow for BioNTech SE?
- What is BioNTech SE quarterly free cash flow year-on-year change?
- What is BioNTech SE TTM free cash flow?
- What is the all-time high TTM free cash flow for BioNTech SE?
- What is BioNTech SE TTM free cash flow year-on-year change?
What is BioNTech SE annual free cash flow?
The current annual free cash flow of BNTX is -$264.58M
What is the all-time high annual free cash flow for BioNTech SE?
BioNTech SE all-time high annual free cash flow is $13.89B
What is BioNTech SE annual free cash flow year-on-year change?
Over the past year, BNTX annual free cash flow has changed by -$5.31B (-105.25%)
What is BioNTech SE quarterly free cash flow?
The current quarterly free cash flow of BNTX is $700.03M
What is the all-time high quarterly free cash flow for BioNTech SE?
BioNTech SE all-time high quarterly free cash flow is $4.76B
What is BioNTech SE quarterly free cash flow year-on-year change?
Over the past year, BNTX quarterly free cash flow has changed by -$907.35M (-56.45%)
What is BioNTech SE TTM free cash flow?
The current TTM free cash flow of BNTX is -$2.15B
What is the all-time high TTM free cash flow for BioNTech SE?
BioNTech SE all-time high TTM free cash flow is $13.78B
What is BioNTech SE TTM free cash flow year-on-year change?
Over the past year, BNTX TTM free cash flow has changed by -$5.14B (-172.00%)